Assessment of serum copper and zinc levels in chronic Schistosoma mansoni patients with and without hepatic involvement before and after praziquantel therapy.

A. M. el Hawy, M. M. Abdel Rahman, S. Rozik, A. F. Fawzy, H. A. el Gammal

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Estimation of serum copper and zinc was carried out on 40 Schistosoma mansoni patients with and without hepatosplenic involvement (group A and B respectively) before and after single oral dose of 40 mg praziquantel therapy as well as 20 normal controls (group C). Full clinical examination and assessment of liver function tests was done. HBsAg positive cases were excluded. The results showed a significant increase in the copper level in both groups (A and B) before treatment when compared to normal controls, and a significant reduction in zinc level only in group B. Following praziquantel therapy the copper level decreased with concomitant increase in the serum zinc level.

Original languageEnglish
Pages (from-to)55-62
Number of pages8
JournalJournal of the Egyptian Society of Parasitology
Volume23
Issue number1
Publication statusPublished - Apr 1 1993
Externally publishedYes

Fingerprint

Praziquantel
Schistosoma mansoni
Zinc
Copper
Liver
Serum
Liver Function Tests
Hepatitis B Surface Antigens
Therapeutics
Control Groups

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Assessment of serum copper and zinc levels in chronic Schistosoma mansoni patients with and without hepatic involvement before and after praziquantel therapy. / el Hawy, A. M.; Abdel Rahman, M. M.; Rozik, S.; Fawzy, A. F.; el Gammal, H. A.

In: Journal of the Egyptian Society of Parasitology, Vol. 23, No. 1, 01.04.1993, p. 55-62.

Research output: Contribution to journalArticle

@article{500f9d7d5b2945c0846d5202593fe80a,
title = "Assessment of serum copper and zinc levels in chronic Schistosoma mansoni patients with and without hepatic involvement before and after praziquantel therapy.",
abstract = "Estimation of serum copper and zinc was carried out on 40 Schistosoma mansoni patients with and without hepatosplenic involvement (group A and B respectively) before and after single oral dose of 40 mg praziquantel therapy as well as 20 normal controls (group C). Full clinical examination and assessment of liver function tests was done. HBsAg positive cases were excluded. The results showed a significant increase in the copper level in both groups (A and B) before treatment when compared to normal controls, and a significant reduction in zinc level only in group B. Following praziquantel therapy the copper level decreased with concomitant increase in the serum zinc level.",
author = "{el Hawy}, {A. M.} and {Abdel Rahman}, {M. M.} and S. Rozik and Fawzy, {A. F.} and {el Gammal}, {H. A.}",
year = "1993",
month = "4",
day = "1",
language = "English",
volume = "23",
pages = "55--62",
journal = "Journal of the Egyptian Society of Parasitology",
issn = "0253-5890",
publisher = "Egyptian Society of Parasitology",
number = "1",

}

TY - JOUR

T1 - Assessment of serum copper and zinc levels in chronic Schistosoma mansoni patients with and without hepatic involvement before and after praziquantel therapy.

AU - el Hawy, A. M.

AU - Abdel Rahman, M. M.

AU - Rozik, S.

AU - Fawzy, A. F.

AU - el Gammal, H. A.

PY - 1993/4/1

Y1 - 1993/4/1

N2 - Estimation of serum copper and zinc was carried out on 40 Schistosoma mansoni patients with and without hepatosplenic involvement (group A and B respectively) before and after single oral dose of 40 mg praziquantel therapy as well as 20 normal controls (group C). Full clinical examination and assessment of liver function tests was done. HBsAg positive cases were excluded. The results showed a significant increase in the copper level in both groups (A and B) before treatment when compared to normal controls, and a significant reduction in zinc level only in group B. Following praziquantel therapy the copper level decreased with concomitant increase in the serum zinc level.

AB - Estimation of serum copper and zinc was carried out on 40 Schistosoma mansoni patients with and without hepatosplenic involvement (group A and B respectively) before and after single oral dose of 40 mg praziquantel therapy as well as 20 normal controls (group C). Full clinical examination and assessment of liver function tests was done. HBsAg positive cases were excluded. The results showed a significant increase in the copper level in both groups (A and B) before treatment when compared to normal controls, and a significant reduction in zinc level only in group B. Following praziquantel therapy the copper level decreased with concomitant increase in the serum zinc level.

UR - http://www.scopus.com/inward/record.url?scp=0027583383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027583383&partnerID=8YFLogxK

M3 - Article

C2 - 8482883

AN - SCOPUS:0027583383

VL - 23

SP - 55

EP - 62

JO - Journal of the Egyptian Society of Parasitology

JF - Journal of the Egyptian Society of Parasitology

SN - 0253-5890

IS - 1

ER -